Product News and Recalls

Nationwide recall of all sterile drugs from compounding pharmacy

An FDA News Release reports of a nationwide voluntary recall of all non-expired sterile drugs distributed by Abrams Royal Compounding Pharmacy. The Dallas company is recalling all intravenous injections, injectable medication, eye drops, nasal sprays, pellet implants, inhalation solutions, and eye ointments made between June 17th and December 17th 2013.

The FDA is alerting all health care professionals to stop using affected products as they may cause serious injury if contaminated. There is one report of a patient who received a mineral IV injections and was later admitted to a California hospital. The patient tested positive for Stenotrophomonas maltophilia. This is a gram-negative bacteria that can cause bloodstream infections as well as pneumonia and meningitis. The compounding pharmacy later found a similar gram-negative bacteria in the same lot.

A director in the FDA’s Center for Drug Evaluation and Research stated, “Using these products puts patients at an unacceptable risk, and we urge health care professionals to follow recall instructions issued by the firm.”

The FDA is also advocating that patients who were administered sterile products produced by Abrams should contact their health care professional. You should speak with a medical professional before making any changes to your healthcare procedure. If you or a loved one suffered an injury as a result of pharmaceutical negligence, you may be entitled to compensation. Contact a Lopez McHugh attorney for a free consultation.